Loading insider details...
Beta
Latest Form 4 (May 27, 2026): Tax Withholding of 12,613 SGMO shares, $2.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 27, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 12,613 | $2.2K |
| Apr 3, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/Award | 2,500,000 | n/a |
| Feb 27, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 5,291 | $2.5K |
| Jan 26, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 102,950 | $41.0K |
| Nov 26, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 7,488 | $3.1K |
| Oct 24, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 126,950 | $83.8K |
| Aug 26, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 7,488 | $4.4K |
| Jul 24, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 126,950 | $60.9K |
| May 28, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 7,488 | $3.5K |
| Apr 24, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 126,950 | $98.6K |